Central Nervous System Pharmacology Practice Questions

Q: A 35-year-old with migraines needs prophylaxis. Which is suitable?

Verapamil. ***Verapamil*** - **Verapamil**, a calcium channel blocker, is often used off-label for **migraine prophylaxis**, particularly in cases where other first-line agents are contraindicated or ineffective. - While not a first-line treatment, it can reduce the frequency and severity of migraine attacks by modulating **vasoconstriction** and **vasodilation**. *Acetaminophen* - **Acetaminophen** is an analgesic used for **acute pain relief**, but it does not have properties that prevent migraine attacks from occurring. - It is unsuitable for long-term **prophylactic management** of migraines. *Sumatriptan* - **Sumatriptan** is a **triptan** medication used for **acute migraine treatment**, meaning it is taken to stop a migraine attack once it has started. - It is not indicated for **migraine prophylaxis** and should not be used regularly to prevent migraines. *Tramadol* - **Tramadol** is an **opioid analgesic** used for moderate to severe pain, and it carries risks of dependence and side effects. - It is not recommended for **migraine prophylaxis** due to its addictive potential and lack of evidence for preventing migraine attacks.

Q: A 65-year-old woman with Parkinson’s disease has been experiencing worsening tremors despite taking levodopa. Which medication can be added to her treatment regimen?

Ropinirole. ***Ropinirole*** - **Ropinirole** is a **dopamine agonist** that directly stimulates dopamine receptors (D2 and D3) in the brain, mimicking the effects of dopamine. It is commonly used as an **adjunct to levodopa** to improve motor symptoms and reduce off-time in Parkinson's disease. - When levodopa alone is insufficient to control symptoms (as in this case), dopamine agonists like ropinirole can help to prolong the therapeutic effects and manage **motor fluctuations**, including tremors, by providing more continuous dopaminergic stimulation. - Ropinirole is FDA-approved for both **monotherapy** in early Parkinson's and as **add-on therapy** in advanced disease with motor complications. *Phenytoin* - **Phenytoin** is an **antieconvulsant** medication primarily used to treat epilepsy and certain types of seizures. - It has **no established role** in the treatment of Parkinson's disease or its associated tremors. *Aspirin* - **Aspirin** is an **NSAID** and antiplatelet agent, commonly used for pain relief, fever reduction, and cardiovascular protection. - It does **not have direct therapeutic effects** on the motor symptoms of Parkinson's disease like tremors. *Gabapentin* - **Gabapentin** is an anticonvulsant and neuropathic pain medication, often used to treat **neuropathic pain**, restless legs syndrome, and seizures. - It is **not effective** for managing the tremors or other motor symptoms of Parkinson's disease.

Q: Why are patients with Parkinson’s disease often treated with levodopa?

To increase dopamine levels in the brain. ***To increase dopamine levels in the brain*** - **Levodopa** is a precursor to **dopamine** and is used to replenish dopamine levels in the brain, as Parkinson's disease is characterized by the degeneration of dopaminergic neurons in the **substantia nigra**. - Since dopamine itself cannot cross the **blood-brain barrier**, levodopa is administered and then converted into dopamine within the brain, thereby alleviating motor symptoms. *To inhibit serotonin production* - **Serotonin** is a neurotransmitter involved in mood, sleep, and appetite, but its production is not the primary target in Parkinson's disease treatment. - While there can be interactions and indirect effects, levodopa's main mechanism does not involve inhibiting serotonin. *To block norepinephrine activity* - **Norepinephrine** is a neurotransmitter involved in alertness and fight-or-flight responses, and while it can be affected in Parkinson's disease, blocking its activity is not the primary goal of levodopa treatment. - Medications that block norepinephrine are typically used for conditions like anxiety or hypertension, not to treat the core symptoms of Parkinson's. *To decrease acetylcholine levels in the brain* - Decreasing **acetylcholine** levels is a strategy used for some Parkinson's symptoms, particularly tremors, using **anticholinergic drugs**. - However, this is a separate pharmacological approach and not the mechanism of action for levodopa, which focuses on increasing dopamine.

Q: How do benzodiazepines exert their sedative effects?

They enhance GABAergic transmission.. ***They enhance GABAergic transmission.*** - Benzodiazepines bind to a specific site on the **GABA-A receptor**, increasing its affinity for the **neurotransmitter GABA**. - This binding leads to an increased frequency of **chloride channel opening**, hyperpolarizing the neuron and making it less excitable, which produces sedative effects. *They increase norepinephrine levels and enhance GABA transmission.* - While benzodiazepines enhance GABA transmission, they do **not primarily increase norepinephrine levels**. - Medications that increase norepinephrine levels, such as certain antidepressants, typically have stimulating rather than sedative effects. *They block dopamine receptors and enhance GABA transmission.* - While benzodiazepines enhance GABA transmission, they do **not block dopamine receptors**. - Blocking dopamine receptors is the primary mechanism of action for many **antipsychotic medications**, which have different pharmacological profiles and side effects compared to benzodiazepines. *They inhibit acetylcholine release and enhance GABA transmission.* - While benzodiazepines enhance GABA transmission, they generally do **not directly inhibit acetylcholine release**. - Muscarinic acetylcholine receptor antagonists (anticholinergics) inhibit acetylcholine and can cause sedation, but this is a distinct mechanism from benzodiazepines.

Q: A patient with multiple sclerosis presents with worsening spasticity. Which of the following drugs would be most appropriate for managing spasticity in this patient?

Baclofen. ***Baclofen*** - **Baclofen** is a **GABA-B receptor agonist** that works by inhibiting excitatory neurotransmission in the spinal cord, effectively reducing **spasticity** in conditions like multiple sclerosis. - It is a first-line treatment for managing chronic severe spasticity due to its effectiveness in muscle relaxation and pain reduction. *Ibuprofen* - **Ibuprofen** is a **non-steroidal anti-inflammatory drug (NSAID)** primarily used for pain and inflammation, and it has no direct effect on muscle spasticity. - While it might alleviate some associated musculoskeletal pain, it does not address the underlying neurological cause of **spasticity**. *Diazepam* - **Diazepam** is a **benzodiazepine** that acts as a **GABA-A receptor positive allosteric modulator**, enhancing GABAergic inhibition and leading to generalized muscle relaxation and sedation. - While it can reduce spasticity, its use is often limited due to significant **sedation**, cognitive impairment, and potential for dependence, especially in long-term management, making it a second-line agent compared to baclofen. *Phenytoin* - **Phenytoin** is an **antiepileptic drug** primarily used to treat seizures and certain neuropathic pains. - It works by blocking voltage-gated sodium channels and has no significant role in the management of **spasticity** in multiple sclerosis.

Q: Which of the following is the most appropriate pharmacological treatment for neuropathic pain in a diabetic patient?

Gabapentin. ***Gabapentin*** - **Gabapentin** is a widely recommended first-line treatment for diabetic neuropathic pain due to its efficacy in modulating neuronal excitability. - It works by binding to the **α2δ subunit of voltage-gated calcium channels**, reducing calcium influx and thereby decreasing the release of excitatory neurotransmitters involved in pain signaling. *Acetaminophen* - **Acetaminophen** is primarily an analgesic and antipyretic, effective for mild to moderate non-neuropathic pain. - It has no significant efficacy against **neuropathic pain**, which involves distinct neurobiological mechanisms. *Tramadol* - **Tramadol** is an opioid analgesic with some serotonin and norepinephrine reuptake inhibition, offering moderate pain relief. - While it can be used for moderate to severe pain, it is generally considered a **second-line agent** for neuropathic pain due to its opioid nature and potential side effects. *Aspirin* - **Aspirin** is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for its anti-inflammatory, analgesic, and antiplatelet effects. - It is **ineffective for neuropathic pain**, which does not typically involve peripheral inflammation as its primary mechanism.

Q: Which of the following drugs is most commonly used for the acute management of migraine?

Sumatriptan. ***Sumatriptan*** - **Triptans** such as sumatriptan are **serotonin 5-HT1B/1D receptor agonists** that cause **vasoconstriction** of intracranial blood vessels and inhibit neuropeptide release. - They are considered **first-line agents** for the acute management of moderate to severe migraine attacks. - Sumatriptan is the most commonly recommended and used triptan for acute migraine treatment. *Amitriptyline* - **Amitriptyline** is a **tricyclic antidepressant** primarily used for **migraine prophylaxis** (prevention), not acute treatment. - Its mechanism involves modulating neurotransmitter levels in the brain to reduce migraine frequency. *Ibuprofen* - **Ibuprofen** is a **non-steroidal anti-inflammatory drug (NSAID)** that can be used for **mild to moderate migraine** attacks. - While effective for milder cases, **triptans are superior** for moderate to severe migraines and are the **standard first-line choice** in acute migraine management guidelines. *Propranolol* - **Propranolol** is a **beta-blocker** primarily used for **migraine prophylaxis**, meaning it is taken regularly to prevent migraines. - It reduces the frequency and severity of migraine attacks but is not effective for stopping an acute attack once it has started.

Q: Which of the following is considered the MOST effective first-line pharmacotherapy for tobacco cessation in non-pregnant adults based on clinical trial evidence?

Varenicline. ***Varenicline*** - **Varenicline** has been shown in clinical trials to be the **most effective single agent** for tobacco cessation, significantly increasing abstinence rates compared to placebo and other pharmacotherapies. - Its mechanism involves **partial agonism of the α4β2 nicotinic acetylcholine receptor**, reducing cravings and withdrawal symptoms while blocking the dopamine reward pathway if nicotine is consumed. *Bupropion* - **Bupropion** is an antidepressant that also aids in smoking cessation by inhibiting the reuptake of **norepinephrine** and **dopamine**. - While effective, its efficacy in clinical trials is generally considered **lower than that of varenicline**. *Nicotine replacement therapy* - **Nicotine replacement therapy (NRT)** delivers nicotine without the harmful chemicals in tobacco, alleviating withdrawal symptoms and cravings. - Although effective and available in many forms (patches, gum, lozenges, inhalers, nasal sprays), **individual NRT products are less effective than varenicline** when used as monotherapy. *Clonidine* - **Clonidine** is an alpha-2 adrenergic agonist that can help reduce nicotine withdrawal symptoms like anxiety and restlessness. - However, its use is **limited by side effects** such as sedation and hypotension, and it is generally considered a **second-line or adjunctive treatment**, with lower efficacy than other first-line agents.

Q: Which drug is contraindicated in a patient with a history of porphyria?

Thiopental. ***Thiopental*** - **Thiopental** is a **barbiturate** known to induce **delta-aminolevulinic acid (ALA) synthase**, which is the rate-limiting enzyme in **heme synthesis**. - This enzyme induction can precipitate acute attacks in patients with **porphyria**, a group of genetic disorders affecting heme production. *Propofol* - **Propofol** is a widely used intravenous anesthetic that is generally considered **safe** in patients with porphyria. - It does not significantly stimulate **ALA synthase** activity or interfere with heme metabolism. *Midazolam* - **Midazolam** is a **benzodiazepine** used for sedation and anesthesia. Like propofol, it is generally considered **safe** in patients with porphyria. - Benzodiazepines do not typically induce **porphyrin synthesis**. *Etomidate* - **Etomidate** is an intravenous anesthetic that acts as a GABA-A receptor modulator. It is also generally considered **safe** for use in patients with porphyria. - While etomidate can sometimes have mild effects on steroid synthesis, it does not significantly impact the **heme biosynthesis pathway** in a way that would trigger porphyric attacks.

Q: What is the first-line treatment for status epilepticus?

Lorazepam. ***Lorazepam*** - **Benzodiazepines** like lorazepam are the **first-line treatment** for status epilepticus due to their rapid onset of action and efficacy in terminating seizures. - Lorazepam is preferred over other benzodiazepines in IV form because of its **longer duration of action** and **lesser lipid solubility**, which keeps it in the central nervous system for longer. *Phenytoin* - **Phenytoin** is typically used as a **second-line agent** or as a maintenance therapy after the initial seizure has been controlled with a benzodiazepine. - It has a slower onset of action compared to benzodiazepines and is primarily used to prevent seizure recurrence. *Valproic acid* - **Valproic acid** is an **anti-epileptic drug** that can be used for status epilepticus, but it is not typically the first-line agent. - It is often considered in cases refractory to benzodiazepines or as an alternative in specific patient populations. *Diazepam* - While **diazepam** is a **benzodiazepine** used for status epilepticus, it has a **shorter duration of action** compared to lorazepam when administered intravenously. - Its rapid redistribution out of the CNS makes it less ideal for sustained seizure control compared to lorazepam in the initial management of status epilepticus.

Question 1

A 35-year-old with migraines needs prophylaxis. Which is suitable?

Accepted Answer

Verapamil

Answer

Acetaminophen

Answer

Sumatriptan

Answer

Tramadol

Question 2

A 65-year-old woman with Parkinson’s disease has been experiencing worsening tremors despite taking levodopa. Which medication can be added to her treatment regimen?

Accepted Answer

Ropinirole

Answer

Phenytoin

Answer

Aspirin

Answer

Gabapentin

Question 3

Why are patients with Parkinson’s disease often treated with levodopa?

Accepted Answer

To increase dopamine levels in the brain

Answer

To decrease acetylcholine levels in the brain

Answer

To inhibit serotonin production

Answer

To block norepinephrine activity

Question 4

How do benzodiazepines exert their sedative effects?

Accepted Answer

They enhance GABAergic transmission.

Answer

They increase norepinephrine levels and enhance GABA transmission.

Answer

They block dopamine receptors and enhance GABA transmission.

Answer

They inhibit acetylcholine release and enhance GABA transmission.

Question 5

A patient with multiple sclerosis presents with worsening spasticity. Which of the following drugs would be most appropriate for managing spasticity in this patient?

Accepted Answer

Baclofen

Answer

Ibuprofen

Answer

Diazepam

Answer

Phenytoin

Question 6

Which of the following is the most appropriate pharmacological treatment for neuropathic pain in a diabetic patient?

Accepted Answer

Gabapentin

Answer

Acetaminophen

Answer

Tramadol

Answer

Aspirin

Question 7

Which of the following drugs is most commonly used for the acute management of migraine?

Accepted Answer

Sumatriptan

Answer

Amitriptyline

Answer

Ibuprofen

Answer

Propranolol

Question 8

Which of the following is considered the MOST effective first-line pharmacotherapy for tobacco cessation in non-pregnant adults based on clinical trial evidence?

Accepted Answer

Varenicline

Answer

Bupropion

Answer

Nicotine replacement therapy

Answer

Clonidine

Question 9

Which drug is contraindicated in a patient with a history of porphyria?

Accepted Answer

Thiopental

Answer

Propofol

Answer

Midazolam

Answer

Etomidate

Question 10

What is the first-line treatment for status epilepticus?

Accepted Answer

Lorazepam

Answer

Phenytoin

Answer

Valproic acid

Answer

Diazepam

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?